JC

Jennifer Buynitzky Ms, Mba, Cft

Director, Scientific Publications at Pacira Pharmaceuticals

Jennifer Buynitzky has a diverse work experience spanning over several companies and roles. Jennifer is currently working as the Director of Scientific Publications at Pacira BioSciences, Inc. Jennifer previously held the position of Associate Director of Medical Communications and Publications at Alnylam Pharmaceuticals from February 2022 to March 2023. Prior to that, Jennifer served as the Sr. Manager of Publications at Biogen from February 2018 to February 2022. Jennifer has also worked as the Associate Director of Scientific Publications at Shire from August 2015 to December 2017. Before that, Jennifer had various roles at MedImmune, including Sr. Manager of Scientific Communications Pipeline from June 2011 to July 2015 and Medical Writing Publication Manager from May 2010 to June 2011. Jennifer was also a Manager of Project Management at Octagon Research Solutions from November 2008 to May 2010. Jennifer has experience in project management as a Project Manager at Complete Healthcare Communications from March 2006 to June 2008. Jennifer began their career as a Managing Editor at Teva Pharmaceuticals (formerly Cephalon) in February 2002. Jennifer also worked at Bristol-Myers Squibb (formerly DuPont Pharmaceuticals Company/DuPont-Merck) as a Publication Manager from May 2001 to December 2001 and as a Staff Scientist from September 1994 to May 2001.

Jennifer Buynitzky has a diverse education background. Jennifer obtained a Certification in Forensic Toxicology from the University of Florida in 2012-2013. Prior to that, they pursued an MBA in Health and Medical Service Administration from Widener University, completing it in 2006. Jennifer also holds a Master of Science (M.S.) degree in Medicinal Chemistry and a Bachelor of Science (B.S.) degree in Chemistry, both from The University of Georgia. The exact years of completion for their M.S. and B.S. degrees are not specified in the provided information.

Links

Previous companies

Biogen logo
Bristol-Myers Squibb logo
Alnylam Pharmaceuticals logo